Edition: International | Greek
MENU

Home » Europe

Health Union: a stronger role for the European Medicines Agency

The EU will be better prepared to manage future health crises by tackling shortages of medicines and medical devices more effectively

By: EBR - Posted: Thursday, January 20, 2022

"New EU platform to monitor and report medicine shortages".
"New EU platform to monitor and report medicine shortages".

The EU will be better prepared to manage future health crises by tackling shortages of medicines and medical devices more effectively.

Parliament endorsed the provisional agreement reached with the Council last year on increasing the powers of the EU’s medicines regulator with 655 votes in favour, 31 against and 8 abstentions.

The European Medicines Agency (EMA) will be better equipped to monitor and mitigate shortages of medicinal products and medical devices considered to be critical in order to address public health emergencies. Two “shortages steering groups”, for medicines and medical devices respectively, will be created and the EMA will set up and manage the European Shortages Monitoring Platform to facilitate data collection.

All actors in the supply chain will be involved more closely, including expert advice from observers representing patients and medical professionals, as well as marketing authorisation holders, wholesale distributors or any other relevant healthcare stakeholders.

The agency will also set up a public webpage with information on shortages. Data related to clinical trials and product information on authorised medicinal products will be made available more timely and transparently.

Quote

Rapporteur Nicolas Gonzalez Casares (S&D, ES) said: “The new regulation makes both the Agency and all actors in the supply chain more transparent, involving them more in the process and fostering synergies between EU agencies. Moreover, we pave the way to promoting clinical trials for the development of vaccines and treatments, boosting transparency on those issues. And, with the new European Shortages Monitoring Platform, we provide the Agency with a key tool to monitor medicines supply and prevent shortages. In short, more transparency, more participation, more coordination, more effective monitoring and more prevention.”

Next steps

Following the final vote in plenary, the text will be published in the EU Official Journal shortly after. The regulation will apply as of 1 March 2022.

Background

As part of building a European Health Union, the Commission proposed on 11 November 2020 a new health security framework fit for future health challenges, based on lessons learnt from combatting COVID-19, which includes a proposal to increase the powers of the European Medicines Agency.

*Source: European Parliament

READ ALSO

EU Actually

Danish social democratic prime minister Mette Frederiksen sometimes tougher on migration than Giorgia Meloni

N. Peter KramerBy: N. Peter Kramer

With her country holding the rotating EU presidency the second half of 2025, Danish prime minister Mette Frederiksen is advocating a stronger EU with more defence and less migration

View 04/2021 2021 Digital edition

Magazine

Current Issue

04/2021 2021

View past issues
Subscribe
Advertise
Digital edition

Europe

Greek MEPs demand tariff-free trade in medicines as new deadline looms

Greek MEPs demand tariff-free trade in medicines as new deadline looms

Greek MEPs Papandreou and Tsiodras warn that US pharma tariffs threaten health and supply chains, urging the Commission to react accordingly.

Business

To save the Single Market, bring back Delors’ 1992 playbook

To save the Single Market, bring back Delors’ 1992 playbook

Most people familiar with EU affairs know the single market is a myth. Hailed as the bedrock of the European Union, it was never completed and is now crumbling.

MARKET INDICES

Powered by Investing.com
All contents © Copyright EMG Strategic Consulting Ltd. 1997-2025. All Rights Reserved   |   Home Page  |   Disclaimer  |   Website by Theratron